United States · 
Who invested in DNALite Therapeutics?
DNALite Therapeutics's investors include National Science Foundation, SOSV and Catalyst Fund.
United States · Venture startup
Who invested in DNALite Therapeutics
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2023, from 1 source
- Latest round
- VentureMar 2023
- Investors
- 3
The rounds
- Mar 2023
Founders and team
From the SEC filings it signed: 1 on the team.
- Mubhij AhmadExecutive Officer, Directori
On the board, as filediAndrew Cain McClaryDavid Cain RabukaDrew Cain LanzaTimothy Paul Day
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about DNALite Therapeutics
How much has DNALite Therapeutics raised?
DNALite Therapeutics has raised 1 round since 2023, none with a disclosed amount.
When did DNALite Therapeutics last raise?
DNALite Therapeutics's most recent round was a Venture in Mar 2023.
Who backed DNALite Therapeutics first?
DNALite Therapeutics's first round on record, in Mar 2023, was backed by National Science Foundation, SOSV and Catalyst Fund.
What stage is DNALite Therapeutics at?
DNALite Therapeutics's latest named round is a Venture, in Mar 2023.
Where is DNALite Therapeutics based?
DNALite Therapeutics is based in the United States.
Companies like DNALite Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.